Get the Stockscreener App
1.97
13.22%
-0.30
After Hours:
1.90
-0.07
-3.55%
Co Diagnostics Inc stock is traded at $1.97, with a volume of 5.75M.
It is down -13.22% in the last 24 hours and down -62.11% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$2.27
Open:
$2.35
24h Volume:
5.75M
Relative Volume:
5.56
Market Cap:
$4.13M
Revenue:
$507.90K
Net Income/Loss:
$-32.18M
P/E Ratio:
-0.0899
EPS:
-21.9125
Net Cash Flow:
$-31.81M
1W Performance:
-14.72%
1M Performance:
-62.11%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$1.96
$2.36
1-Week Range:
$1.96
$3.95
52-Week Range:
$1.96
$3.95
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.97 | 4.76M | 507.90K | -32.18M | -31.81M | -21.91 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Exclusive: Co-Diagnostics expands South Asia reach, targets $13 billion market opportunity - MSN
Co-Diagnostics ships TB testing materials to India for studies - Investing.com
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch - Benzinga
Recap Report: Should I set a stop loss on Co Diagnostics IncWeekly Trend Recap & Expert Approved Trade Ideas - baoquankhu1.vn
Co-Diagnostics expands commercial and distribution territory across South Asia - BioSpectrum Asia
Co-Diagnostics and CoSara expand distribution across South Asia - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia - The Globe and Mail
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings - Sahm
Chart Watch: What analysts say about Co Diagnostics Inc stockTrend Reversal & Low Drawdown Momentum Ideas - baoquankhu1.vn
Nasdaq Down Over 1%; XPeng Shares Fall After Q4 Results - Sahm
Co-Diagnostics Inc. Sees Volatile Movements Amid Market Developments - timothysykes.com
## Recent Developments: Key Market Insights - StocksToTrade
CODX Stock Observes Notable Trends Following Strategic Developments - timothysykes.com
Co-Diagnostics Shares Slip Amidst Market Headwinds and Financial Challenges - StocksToTrade
Co-Diagnostics Inc.’s Stock Surges Amid Strategic Moves and Partnerships - timothysykes.com
Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia - NewMediaWire
Chipmakers Recap: What analysts say about Co Diagnostics Inc stock2026 Sector Moves & Capital Efficiency Focused Strategies - baoquankhu1.vn
CODX Stock Reverses Pre-Market Gains Driven By South Asia Expansion Deal – Retail Highlights ‘Dead Cat Rally’ - Stocktwits
Co-Diagnostics (CODX) Stock Surges 9% Following Major South Asian Market Expansion - Blockonomi
Co-Diagnostics (CODX) Stock Jumps 9% on South Asia Expansion Deal - CoinCentral
Co-Diagnostics Eyes Global Expansion with New Japanese Patent - StocksToTrade
Co-Diagnostics Expands South Asia Footprint, Targeting $13B Diagnostics Opportunity - USA Today
Co-Diagnostics jumps as it expands South Asia distribution footprint - Quiver Quantitative
Co-Diagnostics Latest Moves Juice International Hopes - timothysykes.com
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT) - Benzinga
Why Did CODX Stock Surge 45% In Pre-Market Today? - Stocktwits
Co-Diagnostics, Inc. (CODX) has signed a key agreement to extensively expand its commercial operations and product distribution network across South Asia. - Bitget
Co-Diagnostics expands South Asia distribution territory By Investing.com - Investing.com Canada
Co-Diagnostics expands South Asia distribution territory - Investing.com
Four new South Asian markets lift Co-Diagnostics' target to $13B - Stock Titan
Co-Diagnostics (FRA:C970) Cyclically Adjusted Price-to-FCF : (As of Mar. 19, 2026) - GuruFocus
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN
Will Co Diagnostics Inc benefit from rising consumer demand2026 Sector Review & Weekly High Return Opportunities - baoquankhu1.vn
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast - The Herald Journal
Co-Diagnostics receives Japanese patent for PCR platform By Investing.com - Investing.com Nigeria
Co-Diagnostics to Present at Medical Korea 2026 - GuruFocus
Utah's Co-Diagnostics joins Seoul global healthcare conference - Stock Titan
CODX Technical Analysis & ETF Price Forecast - Intellectia AI
Co-Diagnostics receives Japanese patent for PCR platform - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Co-Diagnostics, Inc.(NasdaqCM: CODX) added to NASDAQ Composite Index - marketscreener.com
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platf - GuruFocus
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies - Barchart
Co-Diagnostics Surges After Market Expansion News - timothysykes.com
Co-Diagnostics regains Nasdaq listing compliance - Investing.com South Africa
Co-Diagnostics Regains Nasdaq Compliance and Listing Status - TipRanks
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - The Herald Journal
Co-Diagnostics (NASDAQ: CODX) cleared to resume trading on Nasdaq - Stock Titan
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):